Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury

ACS Nano

Volumn 9, Issue 2, 2015, Pages 1492-1505

  Saxena, Tarun ^a   Loomis, Kristin H ^a   Pai, S Balakrishna ^a   Karumbaiah, Lohitash ^b   Gaupp, Eric ^a   Patil, Ketki ^a   Patkar, Radhika ^a   Bellamkonda, Ravi V ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Chicago sky blue; inflammation; liposomes; macrophage migration inhibitory factor; nanoparticles; secondary injury; spinal cord injury

Indexed keywords

CELL DEATH; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; LIPOSOMES; MACROPHAGES; NANOPARTICLES; PATHOLOGY; PATIENT REHABILITATION; TISSUE REGENERATION;

CHICAGO; INFLAMMATION; MIGRATION INHIBITORY FACTORS; SECONDARY INJURY; SPINAL CORD INJURIES (SCI);

TARGETED DRUG DELIVERY;

ANTIINFLAMMATORY AGENT; DRUG CARRIER; LIPOSOME; MACROGOL DERIVATIVE; MACROPHAGE MIGRATION INHIBITION FACTOR; NANOMATERIAL; PONTAMINE SKY BLUE; TRYPAN BLUE;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE RAW 264.7; CHEMISTRY; COMPLICATION; MALE; MOUSE; PARTICLE SIZE; RAT; SPINAL CORD INJURY; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG CARRIERS; LIPOSOMES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RAW 264.7 CELLS; SPINAL CORD INJURIES; TIME FACTORS; TRYPAN BLUE;

EID: 84923393986     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn505980z     Document Type: Article

References (93)

1. Silver, J.; Miller, J. H. Regeneration beyond the Glial Scar Nat. Rev. Neurosci. 2004, 5, 146-156
2. Fawcett, J. W.; Asher, R. A. The Glial Scar and Central Nervous System Repair Brain Res. Bull. 1999, 49, 377-391
3. Tator, C. H.; Fehlings, M. G. Review of the Secondary Injury Theory of Acute Spinal-Cord Trauma with Emphasis on Vascular Mechanisms J. Neurosurg. 1991, 75, 15-26
4. Hagg, T.; Oudega, M. Degenerative and Spontaneous Regenerative Processes after Spinal Cord Injury J. Neurotrauma 2006, 23, 264-280
5. Hall, E. D. Antioxidant Therapies for Acute Spinal Cord Injury Neurotherapeutics 2011, 8, 152-167
6. Donnelly, D. J.; Popovich, P. G. Inflammation and Its Role in Neuroprotection, Axonal Regeneration and Functional Recovery after Spinal Cord Injury Exp. Neurol. 2008, 209, 378-388
7. Popovich, P. G.; Whitacre, C. C.; Stokes, B. T. Inflammation, Autoimmunity and Spinal Cord Injury Shock 1999, 12, 2-2
8. Kigerl, K. A.; Gensel, J. C.; Ankeny, D. P.; Alexander, J. K.; Donnelly, D. J.; Popovich, P. G. Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing Either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord J. Neurosci. 2009, 29, 13435-13444
9. Hausmann, O. Post-traumatic Inflammation in Spinal Cord Injury Spinal Cord 2003, 41, 369-378
10. Popovich, P. G.; Wei, P.; Stokes, B. T. Cellular Inflammatory Response after Spinal Cord Injury in Sprague-Dawley and Lewis Rats J. Comp. Neurol. 1997, 377, 443-464
11. Wing, P.; Dalsey, W.; Alvarez, E. Early Acute Management in Adults with Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Professionals J. Spinal Cord Med. 2008, 31, 408-479
12. Breslin, K.; Agrawal, D. The Use of Methylprednisolone in Acute Spinal Cord Injury: A Review of the Evidence, Controversies, and Recommendations Pediatr. Emerg. Care 2012, 28, 1238-1248
13. Bracken, M. B.; Shepard, M. J.; Holford, T. R.; Leo-Summers, L.; Aldrich, E. F.; Fazl, M.; Fehlings, M.; Herr, D. L.; Hitchon, P. W.; Marshall, L. F. Administration of Methylprednisolone for 24 or 48 h or Tirilazad Mesylate for 48 h in the Treatment of Acute Spinal Cord Injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial JAMA 1997, 277, 1597-1604
14. Fehlings, M. G.; Perrin, R. G. The Timing of Surgical Intervention in the Treatment of Spinal Cord Injury: A Systematic Review of Recent Clinical Evidence Spine 2006, 31, S28-S35
15. Calandra, T.; Bernhagen, J.; Mitchell, R. A.; Bucala, R. Macrophage Is an Important and Previously Unrecognized Source of Macrophage-Migration Inhibitory Factor J. Exp. Med. 1994, 179, 1895-1902
16. Calandra, T.; Bucala, R. Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-regulator within the Immune System Crit. Rev. Immunol. 1997, 17, 77-88
17. Calandra, T.; Roger, T. Macrophage Migration Inhibitory Factor: A Regulator of Innate Immunity Nat. Rev. Immunol. 2003, 3, 791-800
18. Koda, M.; Nishio, Y.; Hashimoto, M.; Kamada, T.; Koshizuka, S.; Yoshinaga, K.; Onodera, S.; Nishihira, J.; Moriya, H.; Yamazaki, M. Up-regulation of Macrophage Migration-Inhibitory Factor Expression after Compression-Induced Spinal Cord Injury in Rats Acta Neuropathol. 2004, 108, 31-36
19. Stein, A.; Panjwani, A.; Sison, C.; Rosen, L.; Chugh, R.; Metz, C.; Bank, M.; Bloom, O. Pilot Study: Elevated Circulating Levels of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor in Patients with Chronic Spinal Cord Injury Arch. Phys. Med. Rehabil. 2013, 94, 1498-1507
20. Nishio, Y.; Koda, M.; Hashimoto, M.; Kamada, T.; Koshizuka, S.; Yoshinaga, K.; Onodera, S.; Nishihira, J.; Okawa, A.; Yamazaki, M. Deletion of Macrophage Migration Inhibitory Factor Attenuates Neuronal Death and Promotes Functional Recovery after Compression-Induced Spinal Cord Injury in Mice Acta Neuropathol. 2009, 117, 321-328
21. Emmetsberger, J.; Tsirka, S. E. Microglial Inhibitory Factor (MIF/TKP) Mitigates Secondary Damage Following Spinal Cord Injury Neurobiol. Dis. 2012, 47, 295-309
22. Gensel, J. C.; Donnelly, D. J.; Popovich, P. G. Spinal Cord Injury Therapies in Humans: An Overview of Current Clinical Trials and Their Potential Effects on Intrinsic CNS Macrophages Expert Opin. Ther. Targets 2011, 15, 505-518
23. Al-Abed, Y.; Dabideen, D.; Aljabari, B.; Valster, A.; Messmer, D.; Ochani, M.; Tanovic, M.; Ochani, K.; Bacher, M.; Nicoletti, F. ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis J. Biol. Chem. 2005, 280, 36541-36544
24. Morand, E. F.; Leech, M.; Jurgen, B. MIF: A new Cytokine Link Between Rheumatoid Arthritis and Atherosclerosis Nat. Rev. Drug Discovery 2006, 5, 399-410
25. Bai, F.; Asojo, O. A.; Cirillo, P.; Ciustea, M.; Ledizet, M.; Aristoff, P. A.; Leng, L.; Koski, R. A.; Powell, T. J.; Bucala, R.; Anthony, K. G. A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF) J. Biol. Chem. 2012, 287, 30653-30663
26. Yu, G.; Yi, S.; Wang, M.; Yan, H.; Yan, L.; Su, R.; Gong, Z. The Antinociceptive Effects of Intracerebroventricular Administration of Chicago Sky Blue 6B, a Vesicular Glutamate Transporter Inhibitor Behav. Pharmacol. 2013, 24, 653-658
27. Roseth, S.; Fykse, E. M.; Fonnum, F. Uptake of l -Glutamate into Rat-Brain Synaptic Vesicles: Effect of Inhibitors That Bind Specifically to the Glutamate Transporter J. Neurochem. 1995, 65, 96-103
28. He, Z.; Yan, L.; Yong, Z.; Dong, Z.; Dong, H.; Gong, Z. Chicago Sky Blue 6B, a Vesicular Glutamate Transporters Inhibitor, Attenuates Methamphetamine-Induced Hyperactivity and Behavioral Sensitization in Mice Behav. Brain. Res. 2013, 239, 172-176
29. Mitragotri, S.; Burke, P. A.; Langer, R. Overcoming the Challenges in Administering Biopharmaceuticals: Formulation and Delivery Strategies Nat. Rev. Drug Discovery 2014, 13, 655-672
30. Tyler, J. Y.; Xu, X. M.; Cheng, J. X. Nanomedicine for Treating Spinal Cord Injury Nanoscale 2013, 5, 8821-8836
31. McNeeley, K. M.; Karathanasis, E.; Annapragada, A. V.; Bellamkonda, R. V. Masking and Triggered Unmasking of Targeting Ligands on Nanocarriers To Improve Drug Delivery to Brain Tumors Biomaterials 2009, 30, 3986-3995
32. Ayyagari, A. L.; Zhang, X.; Ghaghada, K. B.; Annapragada, A.; Hu, X.; Bellamkonda, R. V. Long-Circulating Liposomal Contrast Agents for Magnetic Resonance Imaging Magn. Reson. Med. 2006, 55, 1023-1029
33. Han, S.; Arnold, S. A.; Sithu, S. D.; Mahoney, E. T.; Geralds, J. T.; Tran, P.; Benton, R. L.; Maddie, M. A.; D'Souza, S. E.; Whittemore, S. R. Rescuing Vasculature with Intravenous Angiopoietin-1 and Alpha V Beta 3 Integrin Peptide Is Protective after Spinal Cord Injury Brain 2010, 133, 1026-1042
34. Prabhakar, U.; Maeda, H.; Jain, R. K.; Sevick-Muraca, E. M.; Zamboni, W.; Farokhzad, O. C.; Barry, S. T.; Gabizon, A.; Grodzinski, P.; Blakey, D. C. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology Cancer Res. 2013, 73, 2412-2417
35. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
36. Davis, M. E. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
37. Papa, S.; Rossi, F.; Ferrari, R.; Mariani, A.; De Paola, M.; Caron, I.; Fiordaliso, F.; Bisighini, C.; Sammali, E.; Colombo, C. Selective Nanovector Mediated Treatment of Activated Proinflammatory Microglia/Macrophages in Spinal Cord Injury ACS Nano 2013, 7, 9881-9895
38. Wu, J.; Jiang, H.; Bi, Q.; Luo, Q.; Li, J.; Zhang, Y.; Chen, Z.; Li, C. Apamin-Mediated Actively Targeted Drug Delivery for Treatment of Spinal Cord Injury: More than Just a Concept Mol. Pharmaceutics 2014, 11, 3210-3222
39. Chvatal, S. A.; Kim, Y. T.; Bratt-Leal, A. M.; Lee, H. J.; Bellamkonda, R. V. Spatial Distribution and Acute Anti-inflammatory Effects of Methylprednisolone after Sustained Local Delivery to the Contused Spinal Cord Biomaterials 2008, 29, 1967-1975
40. Kim, Y. T.; Caldwell, J. M.; Bellamkonda, R. V. Nanoparticle-Mediated Local Delivery of Methylprednisolone after Spinal Cord Injury Biomaterials 2009, 30, 2582-2590
41. Sawyer, A. J.; Kyriakides, T. R. Nanoparticle-Based Evaluation of Blood-Brain Barrier Leakage during the Foreign Body Response J. Neural Eng. 2013, 10, 016013
42. Ishiyama, M.; Miyazono, Y.; Sasamoto, K.; Ohkura, Y.; Ueno, K. A Highly Water-Soluble Disulfonated Tetrazolium Salt as a Chromogenic Indicator for NADH as Well as Cell Viability Talanta 1997, 44, 1299-1305
43. Chung, I. Y.; Benveniste, E. N. Tumor Necrosis Factor-Alpha Production by Astrocytes: Induction by Lipopolysaccharide, IFN-Gamma, and IL-1-Beta J. Immunol. 1990, 144, 2999-3007
44. Stout, R. D.; Jiang, C. C.; Matta, B.; Tietzel, I.; Watkins, S. K.; Suttles, J. Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences J. Immunol. 2005, 175, 342-349
45. Savaskan, N. E.; Fingerle-Rowson, G.; Buchfelder, M.; Eyüpoglu, I. Y. Brain Miffed by Macrophage Migration Inhibitory Factor Int. J. Cell Biol. 2012, 139573
46. Miranda, K. M.; Espey, M. G.; Wink, D. A. A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite Nitric Oxide 2001, 5, 62-71
47. Scheff, S. W.; Rabchevsky, A. G.; Fugaccia, I.; Main, J. A.; Lumpp, J. E., Jr. Experimental Modeling of Spinal Cord Injury: Characterization of a Force-Defined Injury Device J. Neurotrauma 2003, 20, 179-193
48. Mukundan, S., Jr.; Ghaghada, K. B.; Badea, C. T.; Kao, C.-Y.; Hedlund, L. W.; Provenzale, J. M.; Johnson, G. A.; Chen, E.; Bellamkonda, R. V.; Annapragada, A. A Liposomal Nanoscale Contrast Agent for Preclinical CT in Mice Am. J. Roentgenol. 2006, 186, 300-307
49. Roller, B. T.; Munson, J. M.; Brahma, B.; Santangelo, P. J.; Pai, S. B.; Bellamkonda, R. V. Evans Blue Nanocarriers Visually Demarcate Margins of Invasive Gliomas Drug Delivery Trans. Res. 2013, 1-9
50. Munson, J. M.; Fried, L.; Rowson, S. A.; Bonner, M. Y.; Karumbaiah, L.; Diaz, B.; Courtneidge, S. A.; Knaus, U. G.; Brat, D. J.; Arbiser, J. L. Anti-invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma Sci. Transl. Med. 2012, 4, 127ra36
51. Butt, R. H.; Pfeifer, T. A.; Delaney, A.; Grigliatti, T. A.; Tetzlaff, W. G.; Coorssen, J. R. Enabling Coupled Quantitative Genomics and Proteomics Analyses from Rat Spinal Cord Samples Mol. Cell Proteomics 2007, 6, 1574-1588
52. Kroner, A.; Greenhalgh, A. D.; Zarruk, J. G.; Passos Dos Santos, R.; Gaestel, M.; David, S. TNF and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype in the Injured Spinal Cord Neuron 2014, 83, 1098-1116
53. Fenn, A. M.; Hall, J. C.; Gensel, J. C.; Popovich, P. G.; Godbout, J. P. IL-4 Signaling Drives a Unique Arginase+/IL-1beta+ Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: Consequences of Age-Related Deficits in IL-4Ralpha after Traumatic Spinal Cord Injury J. Neurosci. 2014, 34, 8904-8917
54. Bartus, K.; James, N. D.; Didangelos, A.; Bosch, K. D.; Verhaagen, J.; Yanez-Munoz, R. J.; Rogers, J. H.; Schneider, B. L.; Muir, E. M.; Bradbury, E. J. Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype Following Spinal Cord Contusion Injury J. Neurosci. 2014, 34, 4822-4836
55. Mantovani, A.; Biswas, S. K.; Galdiero, M. R.; Sica, A.; Locati, M. Macrophage Plasticity and Polarization in Tissue Repair and Remodelling J. Pathol. 2013, 229, 176-185
56. David, S.; Kroner, A. Repertoire of Microglial and Macrophage Responses after Spinal Cord Injury Nat. Rev. Neurosci. 2011, 12, 388-399
57. Gilliver, S. C.; Emmerson, E.; Bernhagen, J.; Hardman, M. J. MIF: A Key Player in Cutaneous Biology and Wound Healing Exp. Dermatol. 2011, 20, 1-6
58. Popovich, P. G.; Horner, P. J.; Mullin, B. B.; Stokes, B. T. A Quantitative Spatial Analysis of the Blood Spinal Cord Barrier. 1: Permeability Changes after Experimental Spinal Contusion Injury Exp. Neurol. 1996, 142, 258-275
59. Saxena, T.; Karumbaiah, L.; Gaupp, E. A.; Patkar, R.; Patil, K.; Betancur, M.; Stanley, G. B.; Bellamkonda, R. V. The Impact of Chronic Blood-Brain Barrier Breach on Intracortical Electrode Function Biomaterials 2013, 34, 4703-4713
60. Bilgen, M.; Abbe, R.; Narayana, P. A. Dynamic Contrast-Enhanced MRI Of Experimental Spinal Cord Injury: In Vivo Serial Studies Magn. Reson. Med. 2001, 45, 614-622
61. Alexander, J. K.; Cox, G. M.; Tian, J.-B.; Zha, A. M.; Wei, P.; Kigerl, K. A.; Reddy, M. K.; Dagia, N. M.; Sielecki, T.; Zhu, M. X. Macrophage Migration Inhibitory Factor (MIF) Is Essential for Inflammatory and Neuropathic Pain and Enhances Pain in Response to Stress Exp. Neurol. 2012, 236, 351-362
62. Inácio, A. R.; Ruscher, K.; Leng, L.; Bucala, R.; Deierborg, T. Macrophage Migration Inhibitory Factor Promotes Cell Death and Aggravates Neurologic Deficits after Experimental Stroke J. Cereb. Blood Flow Metab. 2010, 31, 1093-1106
63. Kithcart, A. P.; Cox, G. M.; Sielecki, T.; Short, A.; Pruitt, J.; Papenfuss, T.; Shawler, T.; Gienapp, I.; Satoskar, A. R.; Whitacre, C. C. A Small-Molecule Inhibitor of Macrophage Migration Inhibitory Factor for the Treatment of Inflammatory Disease FASEB J. 2010, 24, 4459-4466
64. Cox, G. M.; Kithcart, A. P.; Pitt, D.; Guan, Z.; Alexander, J.; Williams, J. L.; Shawler, T.; Dagia, N. M.; Popovich, P. G.; Satoskar, A. R. Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation J. Immunol. 2013, 191, 1043-1054
65. Noble, L. J.; Donovan, F.; Igarashi, T.; Goussev, S.; Werb, Z. Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events J. Neurosci. 2002, 22, 7526-7535
66. Kigerl, K. A.; Lai, W.; Rivest, S.; Hart, R. P.; Satoskar, A. R.; Popovich, P. G. Toll-like Receptor (TLR)-2 and TLR-4 Regulate Inflammation, Gliosis, and Myelin Sparing after Spinal Cord Injury J. Neurochem. 2007, 102, 37-50
67. Schmidt, J.; Metselaar, J. M.; Wauben, M. H.; Toyka, K. V.; Storm, G.; Gold, R. Drug Targeting by Long-Circulating Liposomal Glucocorticosteroids Increases Therapeutic Efficacy in a Model of Multiple Sclerosis Brain 2003, 126, 1895-1904
68. Stirling, D. P.; Cummins, K.; Mishra, M.; Teo, W.; Yong, V. W.; Stys, P. Toll-like Receptor 2-Mediated Alternative Activation of Microglia Is Protective after Spinal Cord Injury Brain 2014, 137, 707-723
69. Bastien, D.; Lacroix, S. Cytokine Pathways Regulating Glial and Leukocyte Function after Spinal Cord and Peripheral Nerve Injury Exp. Neurol. 2014, 258, 62-77
70. Bethea, J. R. Spinal Cord Injury-Induced Inflammation: A Dual-Edged Sword Prog. Brain Res. 2000, 128, 33-42
71. Klusman, I.; Schwab, M. E. Effects of Pro-inflammatory Cytokines in Experimental Spinal Cord Injury Brain Res. 1997, 762, 173-184
72. Shechter, R.; London, A.; Varol, C.; Raposo, C.; Cusimano, M.; Yovel, G.; Rolls, A.; Mack, M.; Pluchino, S.; Martino, G. Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice PLoS Med. 2009, 6, e1000113
73. Ferrante, C. J.; Pinhal-Enfield, G.; Elson, G.; Cronstein, B. N.; Hasko, G.; Outram, S.; Leibovich, S. J. The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-like Phenotype Is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling Inflammation 2013, 36, 921-931
74. Bystrom, J.; Evans, I.; Newson, J.; Stables, M.; Toor, I.; van Rooijen, N.; Crawford, M.; Colville-Nash, P.; Farrow, S.; Gilroy, D. W. Resolution-Phase Macrophages Possess a Unique Inflammatory Phenotype That Is Controlled by cAMP Blood 2008, 112, 4117-4127
75. Shechter, R.; Miller, O.; Yovel, G.; Rosenzweig, N.; London, A.; Ruckh, J.; Kim, K.-W.; Klein, E.; Kalchenko, V.; Bendel, P. Recruitment of Beneficial M2Macrophages to Injured Spinal Cord Is Orchestrated by Remote Brain Choroid Plexus Immunity 2013, 38, 555-569
76. Miron, V. E.; Boyd, A.; Zhao, J.-W.; Yuen, T. J.; Ruckh, J. M.; Shadrach, J. L.; van Wijngaarden, P.; Wagers, A. J.; Williams, A.; Franklin, R. J. M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation during CNS Remyelination Nat. Neurosci. 2013, 16, 1211-1218
77. Boutard, V.; Havouis, R.; Fouqueray, B.; Philippe, C.; Moulinoux, J. P.; Baud, L. Transforming Growth-Factor-Beta Stimulates Arginase Activity in Macrophages: Implications for the Regulation of Macrophage Cytotoxicity J. Immunol. 1995, 155, 2077-2084
78. Brancato, S. K.; Albina, J. E. Wound Macrophages as Key Regulators of Repair: Origin, Phenotype, and Function Am. J. Pathol. 2011, 178, 19-25
79. Martinez, F. O.; Gordon, S. The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment F1000Prime Rep. 2014, 6, 13
80. Tyor, W. R.; Avgeropoulos, N.; Ohlandt, G.; Hogan, E. L. Treatment of Spinal Cord Impact Injury in the Rat with Transforming Growth Factor-Beta J. Neurol. Sci. 2002, 200, 33-41
81. Lian, H.; Shim, D. J.; Gaddam, S. S. K.; Rodriguez-Rivera, J.; Bitner, B. R.; Pautler, R. G.; Robertson, C. S.; Zheng, H. IκB Alpha Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response Following Traumatic Brain Injury: Implications for Functional Recovery Mol. Neurodegener. 2012, 7, 47
82. Plesnila, N.; von Baumgarten, L.; Retiounskaia, M.; Engel, D.; Ardeshiri, A.; Zimmermann, R.; Hoffmann, F.; Landshamer, S.; Wagner, E.; Culmsee, C. Delayed Neuronal Death after Brain Trauma Involves P53-Dependent Inhibition of NF-kappaB Transcriptional Activity Cell Death Differ. 2007, 14, 1529-1541
83. Mattson, M. P.; Meffert, M. K. Roles for NF-κB in Nerve Cell Survival, Plasticity, and Disease Cell Death Differ. 2006, 13, 852-860
84. Cho, M. L.; Moon, Y. M.; Heo, Y. J.; Woo, Y. J.; Ju, J. H.; Park, K. S.; Kim, S. I.; Park, S. H.; Kim, H. Y.; Min, J. K. NF-κB Inhibition Leads to Increased Synthesis and Secretion of MIF in Human CD4+ T Cells Immunol. Lett. 2009, 123, 21-30
85. Rothstein, J. D.; Jin, L.; Dykeshoberg, M.; Kuncl, R. W. Chronic Inhibition of Glutamate Uptake Produces a Model of Slow Neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6591-6595
86. Papahadjopoulos, D.; Allen, T.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S.; Lee, K.; Woodle, M.; Lasic, D.; Redemann, C. Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 11460-11464
87. Moghimi, S.; Szebeni, J. Stealth Liposomes and Long Circulating Nanoparticles: Critical Issues in Pharmacokinetics, Opsonization and Protein-Binding Properties Prog. Lipid Res. 2003, 42, 463-478
88. Saxena, T.; Gilbert, J.; Stelzner, D.; Hasenwinkel, J. Mechanical Characterization of the Injured Spinal Cord after Lateral Spinal Hemisection Injury in the Rat J. Neurotrauma 2012, 29, 1747-1757
89. Saxena, T.; Deng, B.; Stelzner, D.; Hasenwinkel, J.; Chaiken, J. Raman Spectroscopic Investigation of Spinal Cord Injury in a Rat Model J. Biomed. Opt. 2011, 16, 027003
90. Livak, K. J.; Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2ΔΔ Ct Method Methods 2001, 25, 402-408
91. Collins, T. J. ImageJ for Microscopy Biotechniques 2007, 43, 25-30
92. Karumbaiah, L.; Norman, S. E.; Rajan, N. B.; Anand, S.; Saxena, T.; Betancur, M.; Patkar, R.; Bellamkonda, R. V. The Upregulation of Specific Interleukin (IL) Receptor Antagonists and Paradoxical Enhancement of Neuronal Apoptosis Due to Electrode Induced Strain and Brain Micromotion Biomaterials 2012, 33, 5983-5996
93. Weischenfeldt, J.; Porse, B. Bone Marrow-Derived Macrophages (BMM): Isolation and Applications CSH Protoc. 2008, 10.1101/pdb.prot5080